Nektar Therapeutics

Nektar Therapeutics is a global biopharmaceutical company headquartered in California, USA. The company is dedicated to the development and commercialization of innovative therapies and drugs and conducts research across multiple therapeutic areas. Nektar Therapeutics owns advanced proprietary technology platforms, including Pegylation technology and NKTR-102 technology. These technologies enhance drug delivery and duration, improve drug efficacy and tolerability. The company’s research spans oncology, immunology, pain management, neuroscience, and autoimmune diseases, among other fields. Nektar aims to develop safer and more effective treatment options, providing patients with better therapeutic choices. Nektar Therapeutics collaborates with other pharmaceutical companies, academic institutions, and the medical community to advance drug research, development, and innovation worldwide.